跳至主要内容
临床试验/NCT03103997
NCT03103997已完成不适用

Wet Heparinized Suction: A Novel Technique to Enhance Tissue Acquisition for Endoscopic Ultrasound Guided Liver Biopsy (EUS-LB): A Prospective Trial

Geisinger Clinic2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2017年1月6日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
2
主要终点
Proportion of cases for which a histologic diagnosis could be made based upon Proportion of cases for which a histologic diagnosis could be made based upon the amount of tissue obtained with the needle

研究概览

简要总结

Since its inception, endoscopic ultrasound with fine needle aspiration (EUS-FNA) has proven a valuable diagnostic and prognostic tool for evaluating a diverse number of pathologies. One such pathology is chronic liver disease (CLD), for which EUS-guided liver biopsy has become a well-accepted method for tissues acquisition. EUS-LB also been compared with percutaneous and transguluar routes showing at least comparable ability to obtain adequate tissue for CLD.

Though enhancements to EUS-FNA, such as dry suction, stylet pull have not proven to demonstrate increased diagnostic accuracy for EUS-FNA, the use of wet suction technique (WEST) has demonstrated the ability to obtain more cellular tissue samples with less blood contamination. In an attempt to obtain further improvement in tissue adequacy, with less blood contamination for EUS-LB, the use of wet heparinized needles will be investigated as compared with conventional EUS-LB for patients with CLD. To do this subjects shall be selected to undergo EUS-LB. As it is the standard to perform 3 needle passes during EUS-LB, subjects will undergo one pass with the following designations: pass 1: conventional EUS-LB [no flush], pass 2: dry heparin heparin [5 milliliters (mL) of heparin flushed and then flushed with air], and pass 3: wet heparin [5 milliliters (mL) of heparin flushed and retained in the needle]. It is predicted that specimens collected with heparinized needle shall show improved adequacy compared with conventional EUS-LB. It is also predicted that the heparin wash will lead to less blood contamination compared with conventional methods. Subjects shall also be monitored for adverse events (AE).

详细描述

3 BACKGROUND AND SIGNIFICANCE Since its inception in 1992, endoscopic ultrasound with fine needle aspiration (EUS-FNA) has continued to be an evolving method for obtaining diagnostically accuracy for gastrointestinal, and extra-luminal pathology. Present society guidelines by both the European Society of Gastrointestinal Endoscopy (ESGE) and American Society of Gastrointestinal Endoscopy (ASGE) have estimated an overall 60-90% diagnostic accuracy of EUS-FNA. However, this accuracy is dependent upon determination of adequacy by expert gastrointestinal pathologists, which may not be available at all centers.

To enhance the diagnostic accuracy of EUS-FNA, several techniques have been described including, acquisition of a core specimen by fine needle biopsy (FNB), the use of a stylet, and suction. Regarding FNB, this technique allows for acquisition of a tissue specimen with intact tissue architecture and therefore more ability for immunohistochemical staining (IHC). The original generations of FNB needles have been studies, demonstrating no noticeable advantage of convention FNA. More recent evolutions of these FNB needles have led to promising preliminary results. For obtaining EUS-guided liver biopsy (EUS-LB), the technical success was 100% and over 91% diagnostic accuracy. Furthermore, EUS-LB appears to have a higher diagnostic accuracy for chronic liver disease (CLD) compared with percutaneous (PLB) and transgulular (TLB) routes. Overall, EUS-FNB appears to be a promising additional to EUS guided tissue acquisition, which shall lead to improved diagnostic accuracy.

In addition to EUS-FNB, both EUS-FNA with stylet use and suction, have gained some notoriety. It is important to note that there is no definitive evidence of improved diagnostic accuracy of EUS-FNA with these methods. One caveat to these supplemental methods for EUS-FNA, would be the use of "wet suction" technique (WEST) for EUS-FNA. The wet suction technique involved the use of 5 milliliters (mL) of 0.9% normal saline (NS) to supplant the traditional column of air present in the FNA needle. When compared to traditional EUS-FNA, the WEST demonstrated an increase in cellularity of the cellblock, improved specimen accuracy and no difference in the blood contamination compared with standard EUS-FNA. Though not specifically an EUS technique, using heparinized needles for PLB of liver lesions, has been described as well. Despite these promising results, this technique has never been employed as an enhancement to EUS-FNA.

Therefore in this study a heparinized solution (wet heparin) shall be employed for the acquisition of tissue in EUS-LB compared with dry heparin and convention EUS-LB. It is predicted that EUS-LB wet heparin will lead to less blood contamination and more adequate tissue acquisition, as compared with dry heparin and conventional EUS-LB.

Primary End Points

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
Single (Outcomes Assessor)

盲法说明

Participants undergo each biopsy in the protocol. The care provider will be directing and performing each needle pass. The outcome assessor will be unaware of each group.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients undergoing EUS-LB
  • Platelet count > 50,000
  • International normalized ratio (INR) < 1.5
  • Age > 18 years
  • Non-pregnant patients

排除标准

  • Age < 18 years
  • Pregnant Patients
  • Inability to obtain consent
  • Anticoagulants or anti-platelet agents use (excluding aspirin) within the last 7-10 days
  • Platelet count < 50,000
  • Presence of ascites
  • Known liver cirrhosis
  • Patients with a heparin or porcine allergy
  • Patients with prior heparin induced thrombocytopenia (HIT)
  • Patient's with religious aversion to porcine-containing products

研究组 & 干预措施

Wet Heparin

Experimental

EUS-guided liver biopsy with needle flushed with heparin, 2 cc of liquid added to suction then attached.

干预措施: EUS-guided liver biopsy (Procedure)

New Needle

Active Comparator

EUS-guided liver biopsy with needle and suction, no preparation

干预措施: EUS-guided liver biopsy (Procedure)

Dry Heparin

Experimental

EUS-guided liver biopsy with needle flushed with heparin, then flushed with air, suction then attached

干预措施: EUS-guided liver biopsy (Procedure)

结局指标

主要结局

Proportion of cases for which a histologic diagnosis could be made based upon Proportion of cases for which a histologic diagnosis could be made based upon the amount of tissue obtained with the needle

时间窗: 7 days

Proportion of cases for which a histologic diagnosis could be made based upon the amount of tissue obtained with the needle

次要结局

  • The Number of patients with visible bleeding after needle biopsy(7 Days)
  • The Number of patients with Pain 1 Day after needle biopsy(1 Days)
  • The Number of patients with Pain 7 Day after needle biopsy(7 Days)
  • The Number of patients with a visible core after needle biopsy(Presence of a visible core specimen (yes/no) at time 7 days)
  • Number of portal tracts (PT) in the specimen (total) under histologic examination(7 Days)
  • The Number of patients with a visible clot after needle biopsy(Presence of visible clots in specimen (yes/no) at time 7 days)
  • The Number of patients requiring medical care after needle biopsy(7 Days)
  • Aggregate Specimen Length under histologic examination(7 Days)
  • Length of the longest piece under histologic examination(7 Days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验